Cargando…

To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question

Detalles Bibliográficos
Autor principal:	Bikdeli, Behnood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148841/ https://www.ncbi.nlm.nih.gov/pubmed/35664534 http://dx.doi.org/10.1002/rth2.12738

Ejemplares similares

Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence
por: Bikdeli, Behnood
Publicado: (2020)

The versatile heparin in COVID‐19
por: Thachil, Jecko
Publicado: (2020)

Gestational Diabetes Mellitus: To Screen or Not to Screen?: Is this really still a question?
por: Simmons, David, et al.
Publicado: (2013)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

Does COVID-19 Escalate Aging Process? A Possible Concern
por: Tayeri, Katayoun, et al.
Publicado: (2022)

COVID-19: Knowns, Unknowns, and Questions
por: Weston, Stuart, et al.
Publicado: (2020)

Closer to FREEDOM From Uncertainty
por: Vaduganathan, Muthiah, et al.
Publicado: (2023)

Heparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit
por: Davenport, Andrew
Publicado: (2008)

Still present after all these years: persistence plus potential toxicity raise questions about the use of atrazine
por: Jablonowski, Nicolai David, et al.
Publicado: (2010)

Diabetes, COVID-19 and Mucormycosis: Unanswered Questions!
por: Rastogi, Ashu, et al.
Publicado: (2021)

Omega-3 Supplements and Cardiovascular Diseases
por: Mohebi-Nejad, Azin, et al.
Publicado: (2014)

Rotating antibiotics in the intensive care unit: feasible, apparently beneficial, but questions remain
por: Pechère, Jean-Claude
Publicado: (2002)

How Covid-19 opened up questions of sociomateriality in healthcare education
por: Cleland, Jennifer, et al.
Publicado: (2020)

COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER)
por: Kochhar, Sonali, et al.
Publicado: (2021)

Five questions to consider when conducting COVID-19 phone research
por: Menon, Shreya, et al.
Publicado: (2021)

Why we still need drugs for COVID‐19 and can't just rely on vaccines
por: Robinson, Bruce W. S., et al.
Publicado: (2021)

Dose Escalation Trial of Desulfated Heparin (ODSH) in Septic Peritonitis
por: Mauro, Katie D., et al.
Publicado: (2022)

A care escalation framework to address lapses in donning and doffing of personal protective equipment during the COVID-19 pandemic
por: Goulding, Anna M., et al.
Publicado: (2020)

To scavenge or not to scavenge, that is STILL the question
por: Allan, Elizabeth G., et al.
Publicado: (2013)

Apps for COVID-19 contact-tracing: Too many questions and few answers
por: Cioffi, A., et al.
Publicado: (2020)

COVID-19 gripped the globe with some unnoticed facts and too many questions
por: Kumar, Awanish
Publicado: (2021)

Still Unanswered Questions about SARS-CoV-2 Mortality and Future Directions for Occupational Medicine
por: Zocchetti, Carlo, et al.
Publicado: (2023)

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions
por: Ungaro, Ryan C., et al.
Publicado: (2021)

COVID-19 and Cardiac Surgery: Still Many Questions and Much Work to Do
por: Rosati, Carlo Maria, et al.
Publicado: (2022)

About the complexity of adult onset Still’s disease… and advances still required for its management
por: Guilpain, Philippe, et al.
Publicado: (2017)

The question of the question: impactful implementation science to address the HIV epidemic
por: Geng, Elvin H., et al.
Publicado: (2022)

Commentary: Are platelet patterns repeated in delayed heparin-induced thrombocytopenia/heparin-induced thrombocytopenia and thrombosis syndrome after cardiac surgery?
por: Kramer, Robert S., et al.
Publicado: (2020)

Is this (still) a man's world?
por: Metaxa, Victoria
Publicado: (2013)

Commentary: Are these times still unprecedented?
por: Chen, Jonathan M.
Publicado: (2021)

Cardiac rupture after ST-elevation myocardial infarction (STEMI): a ‘Stitch’ in time?
por: Nagraj, Sanjana, et al.
Publicado: (2022)

COVID-19: It's still time for health professionals, physical activity enthusiasts and sportive leagues not to let guard down
por: Vancini, Rodrigo L., et al.
Publicado: (2021)

From One Technologist to Another—COVID-19 Questions Answered
por: Beyder, Dmitry D., et al.
Publicado: (2020)

Autonomic dysfunction and post–COVID-19 syndrome: A still elusive link
por: Lanza, Gaetano A.
Publicado: (2022)

Bioengineered heparin: Is there a future for this form of the successful therapeutic?
por: Lord, Megan S, et al.
Publicado: (2014)

Heparin resistance in COVID-19 patients in the intensive care unit
por: White, D., et al.
Publicado: (2020)

Laboratory capacity strengthening in Zimbabwe as part of the COVID-19 response: what has worked? What still needs to be done?
por: Gudza-Mugabe, Muchaneta, et al.
Publicado: (2022)

For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs
por: Shin, Gyeongseon, et al.
Publicado: (2022)

De-escalation of adjuvant chemotherapy for HER2 negative breast cancer
por: Okines, Dr Alicia FC, et al.
Publicado: (2021)

To ATP or Not To ATP: This Is the Question
por: Accardi, Alessio
Publicado: (2008)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5j8bv7nis3dmd41qrubabucgd0